Production & Manufacturing
Business & Industry
Continuous Manufacturing Equipment: Adoption Barriers and Industry Readiness
While continuous manufacturing offers efficiency and quality benefits, high capital costs and technical barriers like PAT integration, feeder accuracy, and RTD modeling slow its widespread adoption in pharma.
Business & Industry
Sustainable Laboratory Equipment Innovations Supporting Green Pharma Initiatives
As the pharmaceutical industry strives for carbon neutrality, the laboratory has become a focal point for sustainability efforts. This article highlights the latest innovations in eco-friendly equipment, from ultra-low temperature freezers to solvent recovery systems, demonstrating how green technology can reduce environmental impact without compromising scientific rigor.
BioPharma
Largest Vaccine Manufacturing Facility in Egypt Launched
Egypt has gone on to mark quite a prominent milestone when it comes to its biopharmaceutical development by laying the foundation stone for the GENNVAX vaccine manufacturing facility, which is all set to become the largest fully integrated vaccine...
Drug Research
UK Plans to Produce Cancer Treatment from Nuclear Waste
Bicycle Therapeutics has entered into a 15-year agreement with the UK Nuclear Decommissioning Authority (NDA) to utilize reprocessed uranium from nuclear reactors for the production of precision cancer therapies.
Under the terms of the deal, announced by the UK government,...
News
Pfizer Signs Around $2.1bn Licensing Deal with YaoPharma
Pfizer has confirmed that it has struck an almost $2.1bn licensing deal with YaoPharma in order to develop as well as commercialize its obesity pill, hence furthering its push into the weight loss spectrum.
It is worth noting that the...
News
โฌ47mn as State Aid for New Aseptic Filling Plant from Vetter
The European Commission has stepped up and given the nod toย โฌ47ย million inย German state aid forย Vetter Pharma, which is a German pharmaceutical service provider. The aid is going to support the establishment when it comes to a new aseptic filling...
News
Eli Lilly to Invest over $6bn on the New Huntsville Facility
With an intent to make the incurable curable, Huntsville may as well become the right place of biopharma production in the next decade.
Eli Lilly, the pharmaceutical giant, announced plans on December 9, 2025, to invest over $6bn on the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















